Novel Tools to Solve a Paradox of Tuberculosis Research

Using Metabolic Fingerprinting to Find New Anti-TB Drugs

CRISPRi meets drug metabolome

08/11/2021: Meet our latest member of the group. Agilent 6545 QTOF ! Welcome to the BerneyLab!

Bioenergetic Inhibitors: Antibiotic Efficacy and Mechanisms of Action in Mycobacterium tuberculosis

Lab Chat with Dr. Michael Berney

Targeting TB Persistence

Contribution to Nature Microbiology Community Blog

Suffocating Persistent TB

A One-two TB Knockout Punch